Re:COVID-19 Therapeutics Accelerator
by hef19898 on Tuesday March 10, 2020 @05:39AM
(#22534055)
No, they should not. What they could do, so, would be to share the raw data with external bodies that have the proper domain knowledge and certification to actually work with it.
[ Parent
| on HN ]
There are no comments on this comment yet.